Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 78 results for "sarabjit kour nangra"

Halol contributes 35-40% to Sun's US sales: Angel Broking

Speaking to CNBC-TV18 on the impact of the surprise audit on the company, Sarabjit Kour Nangra, Angel Broking advises investors not to panic and wait till the details of the audit report are released. According to Nangra, Sun's merger with Ranbaxy ..., 2 weeks ago

3 images for "sarabjit kour nangra", 1 month ago
Business Standard India, 4 months ago
Business Standard India, 5 months ago

Angel Broking maintains 'Buy' on Wipro

Wipro has started a 3 year exercise to become a leaner company. The company is in the process to slim its workflow down by about a third without resorting to mass layoffs, through deploying automation. The company is looking at being around ...
 MyIris1 day ago Angel Broking maintains 'Buy' on Ipca Laboratories  MyIris1 week ago

IT, pharma stocks rally as rupee hits seven-month low

The rupee plummeted to a seven-month low on Monday, making stock investors nervous, but the export-oriented pharma and IT stocks rallied. The market was cautious also because of Tuesday’s money policy review, in which the Reserve Bank of India is widely ...
 The Financial Chronicle2 days ago
DNA India

Angel Broking maintains ''Neutral'' on Sun Pharma

Sun Pharmaceuticals plans to focus on dermatology, post its merger with Ranbaxy Labs, expected to be completed by 2014. The company has lined-up a strategy to make dermatology its biggest segment and expects almost 38-40% of US sales to come from ...
 MyIris2 days ago Sun tanks 6% as Halol unit comes under cloud  DNA India2 weeks ago Sun Pharma falls 4% on surprise inspection reports  Business Today India2 weeks ago Sun Pharma shares dip on surprise audit by USFDA at Halol plant  IndiaVision2 weeks ago

Industry hails move

The decision of the National Pharmaceutical Pricing Authority to withdraw the guidelines for price control on 108 drugs has been welcomed by the pharmaceutical industry. The decision of the National Pharmaceutical Pricing Authority (NPPA) to ...
 The Hindu2 days ago Govt clips NPPA's sweeping powers to control drug prices  Hindu Business Line1 week ago NPPA price control buzz positive for Sanofi, Zydus, Ranbaxy:Angel Broking  MyIris1 week ago Sanofi India surges as NPPA withdraws price control guidelines  Business Standard India1 week ago
Business Standard India

Rollback brings cheer

The pharma industry in India heaved a sigh of relief when the government decided to withdraw a special power that had earlier allowed the National Pharma Pricing Authority to slash prices of several drugs, mostly under the diabetes and cardiac ...
 Financial Chronicle3 days ago Sanofi India surges as govt withdraws NPPA's power on pricing of non-essential drugs  Business Standard India1 week ago

Sanofi India gains 15% in two trading sessions

Sanofi India has gained 4%, extending its 11% rally in the previous session, as the company would benefit the most after the government withdrew National Pharmaceutical Pricing Authority's power that permitted it to fix prices of non-essential ...
 Business Standard India1 week ago

Drug price decontrol will hit cardiac, diabetic patients hard

The National Pharmaceutical Pricing Authority (NPPA) on Monday announced the withdrawal of an internal guideline to fix prices of 108 non-scheduled formulations. Though the decision is disappointing for consumers, mainly cardiac and diabetes ...
 DNA India1 week ago NPPA withdraws internal g'lines on drug pricing  Express Pharma1 week ago
Business Standard India

Tech Mahindra to manage IT operations for Ahlstrom

Tech Mahindra today said it has signed a letter of agreement with Finland-based Ahlstrom to manages its information technology solutions. The multi-year, multi-million Euro contract with Ahlstrom is aimed at increasing efficiency, harmonise ...
 Business Standard India1 week ago Angel Broking recommends 'Accumulate' on Tech Mahindra  MyIris1 week ago

Sanofi shares soar as NPPA withdraws price cap

Sanofi,one of theleading pharmaceutical companies, witnessed a sharp rise in share prices on Tuesday. The company's sharesjumpedafter the National Pharmaceutical Pricing Authority (NPPA) has withdrawn guidelines for price control of 108 ...
 New Indian Express1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less